Skip to content
2000
  • E-ISSN:

Abstract

Introduction:

Clear cell hepatocellular carcinoma (HCC) is a rare subtype of HCC. Histologically, clear cell HCC is characterized by the cytoplasmic accumulation of glycogen with a clear cell appearance, constituting > 80% of tumor cells. Radiologically, clear cell HCC demonstrates early enhancement and washout similar to conventional HCC. Occasionally, enhancing capsule and intratumoral fat are accompanied by clear cell HCC.

Case Description:

A 57-year-old male presented to our hospital with right upper quadrant abdominal pain. Ultrasonography, computed tomography, and magnetic resonance imaging revealed a large mass with a well-defined margin in the right hemiliver. The patient underwent a right hemihepatectomy, and the final histopathology revealed clear cell-type HCC.

Conclusion:

Distinguishing clear cell types from other types of HCC solely based on radiological findings is challenging. If hepatic tumors exhibit encapsulated margins, enhancing rims, intratumoral fat, and arterial phase hyperenhancement/washout pattern despite their large size, consideration of clear cell subtypes in the differential diagnosis list will aid patient management, implying better prognosis than not-otherwise-specified HCC.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmim/10.2174/1573405620666230522144730
2023-08-16
2025-01-10
Loading full text...

Full text loading...

/deliver/fulltext/cmim/20/1/e220523217193.html?itemId=/content/journals/cmim/10.2174/1573405620666230522144730&mimeType=html&fmt=ahah

References

  1. TorbensonM.S. NgI.O.L. ParkY.N. RoncalliM. SakamotoM. Hepatocellular carcinomaWHO Classification of tumours editorial board, editor. Digestive system tumours. WHO classification of tumours series.5th ed.Lyon: International Agency for Research on Cancer2019
    [Google Scholar]
  2. KimH. JangM. ParkY.N.J.J.L.C. Histopathological variants of hepatocellular carcinomas: An update according to the 5th Edition of the WHO classification of digestive system tumors. J Liver Cancer 2020201172410.17998/jlc.20.1.17
    [Google Scholar]
  3. FerrellL.D. KakarS. TerraccianoL.M. WeeA. Tumours and tumourlike lesions of the liver.Hubscher SG: MacSween’s Pathology of the LiverBurt AD, Ferrell LD 7th ed.PhiladelphiaPhiladelphia: Elsevier.2018780879
    [Google Scholar]
  4. IrisD.L. RobertD.O. DavidK. ValerieP. MassimoR. PeterS. KayM.W. FatimaC. IanA.C. The 2019 WHO classification of tumours of the digestive system.Histopathology.2019762182188
    [Google Scholar]
  5. LoyL.M. HsienM.L. JinY.C. Variant hepatocellular carcinoma subtypes according to the 2019 who classification: An imaging-focused review.AJR Am J Roentgenol2022219221222310.2214/AJR.21.26982
    [Google Scholar]
  6. ParkB.V. RonC.G. Yu-HuiH. Histology of hepatocellular carcinoma: Association with clinical features, radiological findings, and locoregional therapy outcomes.J Clin Imaging Sci201995210.25259/JCIS_111_2019
    [Google Scholar]
  7. YangS.H. JW. ON. Clinicopathologic study on clear cell hepatocellular carcinoma.Pathol Int1996467503910.1111/j.1440‑1827.1996.tb03645.x
    [Google Scholar]
  8. JiS.-P. LiQ. DongH. Therapy and prognostic features of primary clear cell carcinoma of the liver.World J Gastroenterol2010166764910.3748/wjg.v16.i6.764
    [Google Scholar]
  9. LaiC.L. WuP.C. LamK.C. ToddD. Histologic prognostic indicators in hepatocellular carcinoma.Cancer19794451677168310.1002/1097‑0142(197911)44:5<1677::AID‑CNCR2820440522>3.0.CO;2‑D227575
    [Google Scholar]
  10. LiuJ.H. TsaiH.L. HsuS.M. HuD.H. ChenS.S. Clear cell and non-clear cell hepatocellular carcinoma: A case report and literature review.Kaohsiung J. Med. Sci.2004202788110.1016/S1607‑551X(09)70088‑915481555
    [Google Scholar]
  11. TakahashiA. SaitoH. KannoY. AbeK. YokokawaJ. IrisawaA. KenjoA. SaitoT. GotohM. OhiraH. Case of clear-cell hepatocellular carcinoma that developed in the normal liver of a middle-aged woman.World J. Gastroenterol.200814112913110.3748/wjg.14.12918176975
    [Google Scholar]
  12. SalvucciM. LemoineA. SaffroyR. AzoulayD. LepèreB. GaillardS. BismuthH. ReynèsM. DebuireB. Microsatellite instability in European hepatocellular carcinoma.Oncogene199918118118710.1038/sj.onc.12022799926933
    [Google Scholar]
  13. EmileJ.F. AL. DA. Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma.Histopathology20013832253110.1046/j.1365‑2559.2001.01096.x
    [Google Scholar]
  14. LiuZ. WeidongM. HuikaiL. Clinicopathological and prognostic features of primary clear cell carcinoma of the liver.Hepatol Res2008383291910.1111/j.1872‑034X.2007.00264.x
    [Google Scholar]
  15. Yongxin ChenJ.Z.H.K. A Giant Primary Clear Cell Hepatocellular Carcinoma in a Young Woman without Cirrhosis.J. Clin. Exp. Pathol.20155322410.4172/2161‑0681.1000224
    [Google Scholar]
  16. JeonS.-W. MyungL.-K. YoungL.-D. Clear cell hepatocellular carcinoma with spontaneous regression of primary and metastatic lesions.Korean J Intern Med20052032687310.3904/kjim.2005.20.3.268
    [Google Scholar]
  17. OutwaterE.K. BhatiaM. SiegelmanE.S. BurkeM.A. MitchellD.G. Lipid in renal clear cell carcinoma: Detection on opposed-phase gradient-echo MR images.Radiology1997205110310710.1148/radiology.205.1.93149709314970
    [Google Scholar]
  18. YoshimitsuK. HondaH. KuroiwaT. IrieH. TajimaT. JimiM. KuroiwaK. NaitoS. MasudaK. MR detection of cytoplasmic fat in clear cell renal cell carcinoma utilizing chemical shift gradient-echo imaging.J. Magn. Reson. Imaging19999457958510.1002/(SICI)1522‑2586(199904)9:4<579::AID‑JMRI12>3.0.CO;2‑S10232518
    [Google Scholar]
  19. WangH. CT findings of primary clear cell carcinoma of liver: With analysis of 19 cases and review of the literature.Abdom Imaging201439 47364310.1007/s00261‑014‑0104‑2
    [Google Scholar]
  20. WillattJ.M. HussainH.K. AdusumilliS. MarreroJ.A. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: Challenges and controversies.Radiology2008247231133010.1148/radiol.247206133118430871
    [Google Scholar]
  21. JeongY.Y. YimN.Y. KangH.K. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: Imaging spectrum and pitfalls of cirrhosis-related nodules.AJR Am. J. Roentgenol.200518541024103210.2214/AJR.04.109616177427
    [Google Scholar]
  22. BrancatelliG. FederleM.P. GrazioliL. CarrB.I. Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 U.S. residents.Radiology20022221899410.1148/radiol.222101076711756710
    [Google Scholar]
  23. KutamiR NakashimaY NakashimaO ShiotaK KojiroM Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans.J Hepatol2000332282910.1016/S0168‑8278(00)80369‑4
    [Google Scholar]
  24. LiuQ.-Y. Hai-GangL. MingG. Primary clear cell carcinoma in the liver: CT and MRI findings.World J Gastroenterol20111779465210.3748/wjg.v17.i7.946
    [Google Scholar]
  25. BuchananT.F.Jr HuvosA.G.J.A.J.o.C.P. Clear-cell carcinoma of the liver. A clinicopathologic study of 13 patients.Am J Clin Pathol19746145293910.1093/ajcp/61.4.529
    [Google Scholar]
  26. ChungYE ParkMS ParkYN Hepatocellular carcinoma variants: Radiologic-pathologic correlation.AJR Am J Roentgenol1931W71310.2214/AJR.07.3947
    [Google Scholar]
  27. SakhujaP. PramodKM. RajeshR. Clear cell hepatocellular carcinoma: Back to the basics for diagnosis.J Cancer Res Ther113656201510.4103/0973‑1482.136041
    [Google Scholar]
  28. MonzawaS. OmataK. ShimazuN. YagawaA. HosodaK. ArakiT. Well-differentiated hepatocellular carcinoma: Findings of US, CT, and MR imaging.Abdom. Imaging199924439239710.1007/s00261990052110390564
    [Google Scholar]
  29. GrazioliL. OlivettiL. FugazzolaC. BenettiA. StangaC. DettoriE. GalloC. MatricardiL. GiacobbeA. ChiesaA. The pseudocapsule in hepatocellular carcinoma: Correlation between dynamic MR imaging and pathology.Eur. Radiol.199991626710.1007/s0033000506299933382
    [Google Scholar]
  30. TanY. XiaoE. Rare hepatic malignant tumors: Dynamic CT, MRI, and clinicopathologic features: with analysis of 54 cases and review of the literature.Abdom. Imaging201338351152610.1007/s00261‑012‑9918‑y22669313
    [Google Scholar]
  31. MurakataL.A. IshakK.G. NzeakoU.C. Clear cell carcinoma of the liver: A comparative immunohistochemical study with renal clear cell carcinoma.Mod. Pathol.200013887488110.1038/modpathol.388015610955454
    [Google Scholar]
  32. KimB. LeeJ.H. KimJ.K. KimH.J. KimY.B. LeeD. The capsule appearance of hepatocellular carcinoma in gadoxetic acid-enhanced MR imaging.Medicine20189725e1114210.1097/MD.000000000001114229924016
    [Google Scholar]
  33. AnC. RheeH. HanK. ChoiJ.Y. ParkY.N. ParkM.S. KimM.J. ParkS. Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.Eur. Radiol.20172762610261810.1007/s00330‑016‑4634‑627770230
    [Google Scholar]
  34. IshigamiK. YoshimitsuK. NishiharaY. IrieH. AsayamaY. TajimaT. NishieA. HirakawaM. UshijimaY. OkamotoD. TaketomiA. HondaH. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: Correlation with histopathologic findings.Radiology2009250243544310.1148/radiol.250107170219095782
    [Google Scholar]
  35. Dioguardi BurgioM. PiconeD. CabibboG. MidiriM. LagallaR. BrancatelliG. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: Comparison of gadoxetic acid and gadobenate dimeglumine.Abdom. Radiol.20164181546155410.1007/s00261‑016‑0726‑727052455
    [Google Scholar]
  36. RimolaJ. FornerA. TremosiniS. ReigM. VilanaR. BianchiL. Rodríguez-LopeC. SoléM. AyusoC. BruixJ. Non-invasive diagnosis of hepatocellular carcinoma ≤2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI.J. Hepatol.20125661317132310.1016/j.jhep.2012.01.00422314420
    [Google Scholar]
  37. YeX.P. LiL.Q. PengT. XiaoK.Y. SuZ.X. ShangL.M. SuM. XuB.H. [Diagnosis and treatment of primary clear cell carcinoma of the liver].Zhonghua Zhong Liu Za Zhi2010321646620211073
    [Google Scholar]
  38. LaoX.M. ZhangY.Q. JinX. LinX.J. GuoR.P. LiG.H. LiJ.Q. Primary clear cell carcinoma of liver--clinicopathologic features and surgical results of 18 cases.Hepatogastroenterology2006536712813216506391
    [Google Scholar]
  39. AvilaM.A. BerasainC. SangroB. PrietoJ. New therapies for hepatocellular carcinoma.Oncogene200625273866388410.1038/sj.onc.120955016799628
    [Google Scholar]
  40. BruixJ. ShermanM. Management of hepatocellular carcinoma.Hepatology20054251208123610.1002/hep.2093316250051
    [Google Scholar]
  41. LiT. FanJ. QinLun-Xiu Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver.Ann Surg Oncol201118719556310.1245/s10434‑010‑1540‑z
    [Google Scholar]
  42. ParfittJ.R. MarottaP. AlGhamdiM. WallW. KhakharA. SuskinN.G. QuanD. McAllisterV. GhentC. LevstikM. McLeanC. ChakrabartiS. GarciaB. DrimanD.K. Recurrent hepatocellular carcinoma after transplantation: Use of a pathological score on explanted livers to predict recurrence.Liver Transpl.200713454355110.1002/lt.2107817394152
    [Google Scholar]
  43. UenoS. TanabeG. YoshidaA. YoshidomeS. TakaoS. AikouT. Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis.Cancer199986224825410.1002/(SICI)1097‑0142(19990715)86:2<248::AID‑CNCR8>3.0.CO;2‑110421260
    [Google Scholar]
  44. PandeyD. LeeK.H. WaiC.T. WagholikarG. TanK.C. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection.Ann. Surg. Oncol.200714102817282310.1245/s10434‑007‑9518‑117690940
    [Google Scholar]
  45. WeiX PengleiG WenjunL Edmondson grade predicts survival of patients with primary clear cell carcinoma of liver after curative resection: A retrospective study with long-term follow-up.Asia Pac J Clin Oncol2017135e312e32010.1111/ajco.12494
    [Google Scholar]
  46. McDermottW.V. CadyB. GeorgiB. SteeleG.Jr KhettryU. Primary cancer of the liver. Evaluation, treatment, and prognosis.Arch. Surg.1989124555255410.1001/archsurg.1989.014100500420072540731
    [Google Scholar]
  47. ShahS GuptaS ShetT Metastatic clear cell variant of hepatocellular carcinoma with an occult hepatic primary.Hepatobiliary Pancreat Dis Int2005423067
    [Google Scholar]
  48. Chin’ombeN. ChavhundukaE. MatariraH.T. Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe.Infect. Agent. Cancer2009411510.1186/1750‑9378‑4‑1519814789
    [Google Scholar]
  49. BarazaniY. HiattJ.R. TongM.J. BusuttilR.W. Chronic viral hepatitis and hepatocellular carcinoma.World J. Surg.20073161245125010.1007/s00268‑007‑9041‑317440771
    [Google Scholar]
  50. ButD.Y.K. LaiC.L. YuenM.F. Natural history of hepatitis-related hepatocellular carcinoma.World J. Gastroenterol.200814111652165610.3748/wjg.14.165218350595
    [Google Scholar]
/content/journals/cmim/10.2174/1573405620666230522144730
Loading
/content/journals/cmim/10.2174/1573405620666230522144730
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test